PI Industries Ltd.    
29 Oct 2020, 12:00AM
2197.20
1.81%
Axis Direct
We recommend a BUY on PI INDUSTRIES with a Target Price of Rs 2280, an upside of ~7% from CMP of Rs. 2130 and Stop Loss Rs 1980
PI Industries Ltd. has an average target of 2148.56 from 10 brokers.
PI Industries Ltd.    
09 Oct 2020
2197.20
1.81%
buy
default
Axis Direct increased Buy price target of PI Industries Ltd. to 2280.0 on 29 Oct, 2020.
PI Industries Ltd.    
05 Oct 2020
2197.20
1.81%
Axis Direct
We initiate coverage on PI Industries with BUY and Target Price of Rs. 2155/share with a 10% upside as we value the stock at 33x P/E on its FY23E EPS given its unique business model aided by steady growing CSM and Domestic Formulation business and higher growth in adjacent segments
PI Industries Ltd. has an average target of 2148.56 from 10 brokers.
PI Industries Ltd.    
10 Sep 2020
2197.20
1.81%
Nirmal Bang Institutional
Dip in RoE offsets business and earnings growth outlook PI Industries offers visible growth in topline and earnings from three new units started over 4QFY20 and 1HFY21 as per the Indian agrochem CSM leader's FY20 annual report. The management has also discussed initiatives to beef up R&D; capabilities (i) to increase the pace of commercialization of molecules to at least 10 every year and (ii) new chemistry, including the latest in flourination process. New product launches and Isagro Asia acquisition are added growth catalysts that will likely support healthy growth in PI's CSM segment. This is based on innovators looking to Indian companies as alternative sources for...
default
PI Industries Ltd. is trading above all available SMAs
PI Industries Ltd.    
07 Sep 2020
2197.20
1.81%
buy
Accumulate: PI Industries Ltd.
Dolat Capital
Plodded along at first, forging ahead now ISAGRO's acquisition, a Rs 20.0bn QIP a prelude to inorganic growth, 22 patent applications, a USD 1.5bn CSM order book, introduction of an intermediate used in COVID-19 drug and commissioning of 2 new multiproduct plants, 2 new products in CSM and 3 new products in the domestic business have been new feathers in the cap for PI Industries during FY20. PI Industries' foray into pharmaceuticals has been a manifestation of their perseverance. PI Industries' FY20 annual report...
Number of FIIs/FPIs holding stock rose by 85 to 315 in Sep 2020 qtr.
PI Industries Ltd.    
11 Aug 2020
2197.20
1.81%
Chola Wealth Direct
Background: Incorporated in 1947, PI (erstwhile Pesticides India) focuses on agri-input, custom synthesis and polymer compounding with strength of over 1,100 employees. The company currently operates three formulation and two manufacturing facilities as well as five multi-product plants across Gujarat and Jammu, and one R&D; unit in Rajasthan at Udaipur. PI is one of India's leading players in the agri-input industry, primarily dealing in agro-chemicals, specialty fertilizers, plant nutrients and seeds. The company has exclusive rights with several global corporations for distribution in India and is evaluating prospects to further expand their product portfolio. The company has a strong product portfolio as a result of exclusive tie-ups with leading agro-chemical, pharmaceutical and fine chemical...
PI Industries Ltd. has gained 38.23% in the last 6 Months
PI Industries Ltd.    
10 Aug 2020
2197.20
1.81%
buy
Accumulate: PI Industries Ltd.
Geojit BNP Paribas
PI Industries manufactures plant protection & specialty plant nutrient products and solutions under its agri-inputs business. It is also one of India's leading custom synthesis (CSM) companies engaged in providing contract...
PI Industries Ltd. is trading above all available SMAs
PI Industries Ltd.    
07 Aug 2020
2197.20
1.81%
Nirmal Bang Institutional
We maintain Accumulate on PI industries (PI) after raising our PE-based target price (TP) by 18.2% to Rs1972 post results- in line vs. NB estimates, but above the street's. We have also tweaked our base case EPS forecast to build in the 8.97% equity dilution post the recent QIP. Our new TP is based on 33x PE on our proforma FY22E-23E average EPS estimate assuming potential earnings from proposed investments on capacity building through M&A; to be funded using the Rs20bn equity raised through a QIP last month. Management has a crack team working full time on potential targets in non-agro CSM, especially in pharma space, including overseas assets and expects to invest the QIP funds in full over the next 15-18 months (2H...
default
Axis Direct increased Buy price target of PI Industries Ltd. to 2280.0 on 29 Oct, 2020.
PI Industries Ltd.    
06 Aug 2020
2197.20
1.81%
BOB Capital Markets Ltd.
PI Industries (PI) reported a strong beat in Q1FY21 with sharp QoQ EBITDA recovery.
PI Industries Ltd. has gained 56.86% in the last 1 Year
PI Industries Ltd.    
06 Aug 2020
2197.20
1.81%
Prabhudas Lilladhar
PI continued its outperformance in Q1'21 with topline/EBITDA/APAT growth of 41%/51%/44% driven by solid 76% growth in domestic business. The management continued to maintain positive commentary across CSM and domestic segments driven by stable demand outlook, continuous rise in new enquiries, entry in pharma value chain and ramp up of molecules & facilities commercialization. It plans to fully deploy QIP proceeds of Rs20bn in the next 5-6 quarters and expects to earn the existing 18-20% RoE over a period of...
PI Industries Ltd. has an average target of 2148.56 from 10 brokers.